Sanon Bio (688117.SH): Subsidiary signs GLP-1 peptide active pharmaceutical ingredient sales contract not exceeding 0.35 billion yuan

Zhitong Finance · Sep 17 16:47

Shengnuo Biology (688117.SH) announced that its wholly-owned subsidiary, Chengdu Shengnuo Biopharmaceutical Co., Ltd. ("Shengnuo...

Zhixun Finance APP news, Shengnuo Biology (688117.SH) announced that its wholly-owned subsidiary, Chengdu Shengnuo Biopharmaceutical Co., Ltd. ("Shengnuo Biopharmaceutical") recently signed a "Product Purchase Contract" with a certain customer, supplying GLP-1 peptide active pharmaceutical ingredient to the contracting party for a contract value not exceeding RMB 0.35 billion (tax included).

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

圣诺生物(688117.SH)：子公司签订不超3.5亿元GLP-1多肽原料药销售合同

Sanon Bio (688117.SH): Subsidiary signs GLP-1 peptide active pharmaceutical ingredient sales contract not exceeding 0.35 billion yuan

Risk Disclaimer

Statement